Logo image of CORZ

CORE SCIENTIFIC INC (CORZ) Stock Fundamental Analysis

NASDAQ:CORZ - Nasdaq - US21874A1060 - Common Stock - Currency: USD

6.63  +0.04 (+0.61%)

After market: 6.5638 -0.07 (-1%)

Fundamental Rating

3

CORZ gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. While CORZ seems to be doing ok healthwise, there are quite some concerns on its profitability. CORZ is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year CORZ has reported negative net income.
In the past year CORZ had a positive cash flow from operations.
In the past 5 years CORZ reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: CORZ reported negative operating cash flow in multiple years.
CORZ Yearly Net Income VS EBIT VS OCF VS FCFCORZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B -2B

1.2 Ratios

Looking at the Return On Assets, with a value of -70.20%, CORZ is doing worse than 86.57% of the companies in the same industry.
Industry RankSector Rank
ROA -70.2%
ROE N/A
ROIC N/A
ROA(3y)-123.52%
ROA(5y)-75.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CORZ Yearly ROA, ROE, ROICCORZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

Looking at the Gross Margin, with a value of 23.71%, CORZ is doing worse than 80.57% of the companies in the same industry.
CORZ's Gross Margin has improved in the last couple of years.
CORZ does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 23.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.55%
GM growth 5Y6.04%
CORZ Yearly Profit, Operating, Gross MarginsCORZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

5

2. Health

2.1 Basic Checks

CORZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CORZ has been reduced compared to 1 year ago.
Compared to 5 years ago, CORZ has less shares outstanding
The debt/assets ratio for CORZ has been reduced compared to a year ago.
CORZ Yearly Shares OutstandingCORZ Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
CORZ Yearly Total Debt VS Total AssetsCORZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

CORZ has an Altman-Z score of -1.90. This is a bad value and indicates that CORZ is not financially healthy and even has some risk of bankruptcy.
CORZ has a worse Altman-Z score (-1.90) than 77.03% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.9
ROIC/WACCN/A
WACC9.77%
CORZ Yearly LT Debt VS Equity VS FCFCORZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

A Current Ratio of 6.72 indicates that CORZ has no problem at all paying its short term obligations.
CORZ has a Current ratio of 6.72. This is amongst the best in the industry. CORZ outperforms 90.46% of its industry peers.
A Quick Ratio of 6.72 indicates that CORZ has no problem at all paying its short term obligations.
The Quick ratio of CORZ (6.72) is better than 90.46% of its industry peers.
Industry RankSector Rank
Current Ratio 6.72
Quick Ratio 6.72
CORZ Yearly Current Assets VS Current LiabilitesCORZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

4

3. Growth

3.1 Past

CORZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1600.00%.
The Revenue has been growing slightly by 1.65% in the past year.
The Revenue has been growing by 53.71% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-1600%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
Revenue 1Y (TTM)1.65%
Revenue growth 3Y-2.11%
Revenue growth 5Y53.71%
Sales Q2Q%-33.12%

3.2 Future

CORZ is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.45% yearly.
Based on estimates for the next years, CORZ will show a small growth in Revenue. The Revenue will grow by 6.90% on average per year.
EPS Next Y99.44%
EPS Next 2Y44.06%
EPS Next 3Y27.45%
EPS Next 5YN/A
Revenue Next Year-4.36%
Revenue Next 2Y32.37%
Revenue Next 3Y35.39%
Revenue Next 5Y6.9%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CORZ Yearly Revenue VS EstimatesCORZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
CORZ Yearly EPS VS EstimatesCORZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CORZ. In the last year negative earnings were reported.
Also next year CORZ is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CORZ Price Earnings VS Forward Price EarningsCORZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150

4.2 Price Multiples

77.74% of the companies in the same industry are more expensive than CORZ, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.94
CORZ Per share dataCORZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

CORZ's earnings are expected to grow with 27.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.06%
EPS Next 3Y27.45%

More info and screens

0

5. Dividend

5.1 Amount

CORZ does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CORE SCIENTIFIC INC

NASDAQ:CORZ (4/17/2025, 8:10:38 PM)

After market: 6.5638 -0.07 (-1%)

6.63

+0.04 (+0.61%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)05-08 2025-05-08
Inst Owners90.02%
Inst Owner Change0%
Ins Owners4.45%
Ins Owner Change1.55%
Market Cap1.96B
Analysts84.55
Price Target19.89 (200%)
Short Float %15.88%
Short Ratio2.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-878.49%
Min EPS beat(2)-1154.44%
Max EPS beat(2)-602.54%
EPS beat(4)1
Avg EPS beat(4)-3913.43%
Min EPS beat(4)-13917.4%
Max EPS beat(4)20.66%
EPS beat(8)3
Avg EPS beat(8)-2043.44%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.79%
Min Revenue beat(2)-8.73%
Max Revenue beat(2)-6.86%
Revenue beat(4)2
Avg Revenue beat(4)1.41%
Min Revenue beat(4)-8.73%
Max Revenue beat(4)13.65%
Revenue beat(8)3
Avg Revenue beat(8)-5.11%
Revenue beat(12)5
Avg Revenue beat(12)-4.66%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-2.5%
EPS NQ rev (1m)-9.83%
EPS NQ rev (3m)-56.32%
EPS NY rev (1m)-118.79%
EPS NY rev (3m)-112.18%
Revenue NQ rev (1m)-4.29%
Revenue NQ rev (3m)-9.2%
Revenue NY rev (1m)-21.54%
Revenue NY rev (3m)-18.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.83
P/FCF N/A
P/OCF 45.58
P/B N/A
P/tB N/A
EV/EBITDA 20.94
EPS(TTM)-6.12
EYN/A
EPS(NY)-0.03
Fwd EYN/A
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.15
OCFY2.19%
SpS1.73
BVpS-2.78
TBVpS-2.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -70.2%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 23.71%
FCFM N/A
ROA(3y)-123.52%
ROA(5y)-75.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18.55%
GM growth 5Y6.04%
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 10.17
Cap/Depr 84.09%
Cap/Sales 18.64%
Interest Coverage N/A
Cash Conversion 40.63%
Profit Quality N/A
Current Ratio 6.72
Quick Ratio 6.72
Altman-Z -1.9
F-Score4
WACC9.77%
ROIC/WACCN/A
Cap/Depr(3y)122.96%
Cap/Depr(5y)360.66%
Cap/Sales(3y)38.66%
Cap/Sales(5y)43.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1600%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-200%
EPS Next Y99.44%
EPS Next 2Y44.06%
EPS Next 3Y27.45%
EPS Next 5YN/A
Revenue 1Y (TTM)1.65%
Revenue growth 3Y-2.11%
Revenue growth 5Y53.71%
Sales Q2Q%-33.12%
Revenue Next Year-4.36%
Revenue Next 2Y32.37%
Revenue Next 3Y35.39%
Revenue Next 5Y6.9%
EBIT growth 1Y-149.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year917.07%
EBIT Next 3Y216.42%
EBIT Next 5Y187.34%
FCF growth 1Y-208.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-34.12%
OCF growth 3YN/A
OCF growth 5YN/A